Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.

Author: BrandiL, DaugaardH, EgfjordM, LewinE, OlgaardK, StormT, van WowernN

Paper Details 
Original Abstract of the Article :
The long-term effects of high dose steroid treatment with either prednisone (PDN) or deflazacort (DFZ) were examined on various parts of the skeleton in 29 patients with nephrotic syndrome. All had normal skeleton at the start of the steroid treatment. At the beginning, PDN was given as 80 mg/day an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/BF00582160

データ提供:米国国立医学図書館(NLM)

The Price of Protection: Steroids and Osteoporosis in Nephrotic Patients

The quest to protect the body from disease often involves a delicate balancing act, as treatments can sometimes have unintended consequences. This double-blind study explores the impact of high-dose steroid therapy on bone health in patients with nephrotic syndrome, a condition characterized by excessive protein loss in the urine. The researchers compared the effects of prednisone and deflazacort, two commonly prescribed steroids, on bone mineral content in various parts of the skeleton, including the lumbar spine, forearm, and mandible.

Bone Loss: A Side Effect of Steroid Therapy

The study found that both prednisone and deflazacort led to significant bone loss in all parts of the skeleton, but the rate of bone loss varied depending on the bone region and the type of steroid used. Prednisone was associated with a higher rate of bone loss in the forearm compared to deflazacort. This finding suggests that deflazacort may offer a more bone-sparing alternative for patients who require long-term steroid therapy.

Protecting Your Bones: A Desert Oasis of Healthy Habits

These findings highlight the potential risk of osteoporosis, a condition characterized by weak and brittle bones, associated with long-term steroid therapy. Like a lone traveler in the desert, it's essential to take proactive measures to protect your bone health. This includes maintaining a balanced diet rich in calcium and vitamin D, engaging in regular weight-bearing exercise, and discussing potential risks and preventive strategies with your healthcare provider.

Dr.Camel's Conclusion

This study underscores the importance of monitoring bone health in patients receiving long-term steroid therapy. While steroids can be life-saving, it's crucial to consider the potential impact on bone density and take proactive measures to mitigate risks. Remember, just as a desert traveler needs to replenish their water supply, we need to nourish our bones with the right nutrients and support to keep them strong and healthy.

Date :
  1. Date Completed 1992-10-22
  2. Date Revised 2019-08-27
Further Info :

Pubmed ID

1525702

DOI: Digital Object Identifier

10.1007/BF00582160

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.